Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tysabri Vaccination Response in Relapsing MS
NCT00536120Phase 4Completed
- Sponsor
- Biogen
- Start
- Jan 2008
- Primary completion
- Nov 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of natalizumab in multiple sclerosis (MS), sponsored by Biogen. Started Jan 2008; status: completed.
02
Drugs
natalizumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00536120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536120.